Eywa Pharma Inc
51 drugs in NADAC|51 Generic,0 Brand
View Recalls (1)Eywa Pharma Inc lists 51 NDCs in the CMS NADAC file (51 generic, 0 brand), at an average NADAC of $0.43 per unit, with a week-over-week move of -0.3% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.
Total Drugs
51
51G / 0B
Avg Price / Unit
$0.4285
$0.05 – $4.92
Avg 7d Change
-0.34%
Across 35 drugs with changes
7d Activity
of 51 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Hydrocodone Bitartrate and Acetaminophen market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Opioid Agonist therapeutic class
Review the broader class where Eywa Pharma Inc has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Eywa Pharma Inc make?
Eywa Pharma Inc lists 51 NDCs in the CMS NADAC file — 51 generic and 0 brand products.
What is the average price of Eywa Pharma Inc drugs?
The average NADAC across Eywa Pharma Inc's portfolio is $0.4285 per unit, ranging from $0.0491 to $4.9220.
What types of drugs does Eywa Pharma Inc make?
Eywa Pharma Inc makes drugs across 13 FDA pharmacologic classes. The most common by NDC count are Opioid Agonist (30), beta-Adrenergic Blocker (6), Mood Stabilizer (3), Corticosteroid (3), Serotonin-3 Receptor Antagonist (2).
Has Eywa Pharma Inc had any drug recalls?
1 FDA recall is matched to Eywa Pharma Inc in the openFDA feed, most recently on Nov 10, 2020.
How has Eywa Pharma Inc's pricing changed recently?
Over the past 7 days, 17 Eywa Pharma Inc products rose and 18 fell, with a portfolio-wide average change of -0.3%.
FDA Recalls (1)
Recalls matched by company name. Verify current status with FDA.
Levetiracetam Tablets, USP 500 mg, packaged in 120-count bottle, Rx only, Manufactured by: VKT Pharma Private Limited Srikakulam, India - 532 409, Manufactured for: Eywa Pharma Inc. 2 Research Way, Floor 3 Princeton, NJ 08540, NDC 71930-063-52
Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets.